Details for New Drug Application (NDA): 076405
✉ Email this page to a colleague
The generic ingredient in TRI-LEGEST 21 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 076405
Tradename: | TRI-LEGEST 21 |
Applicant: | Barr |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG | ||||
Approval Date: | Oct 26, 2007 | TE: | RLD: | No |
Complete Access Available with Subscription